News
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...
12h
Medical Device Network on MSNFDA grants expanded labelling approval of Boston Scientific’s PFA systemThe US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...
Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, ...
Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...
Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...
Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the ...
Boston Scientific (NYSE: BSX) announced that the FDA approved an expansion to the label of its Farapulse pulsed field ...
Boston Scientific (NYSE:BSX) recently achieved FDA approval to expand the FARAPULSE™ Pulsed Field Ablation (PFA) System's use, enhancing treatment options for persistent atrial fibrillation. This ...
Boston Scientific Corp. gained a second U.S. FDA approval for its Farapulse pulsed field ablation catheter, expanding its use into drug-refractory, symptomatic persistent atrial fibrillation (AF) in ...
Memorial Health System’s Department of Cardiology has announced the successful launch of the FARAPULSE Pulsed Field Ablation ...
Atrial fibrillation, or AFib, is the most common type of heart arrhythmia. Atrial fibrillation, ... Farapulse uses electrical signals. “The Farapulse is non-thermal.
Hosted on MSN8mon
Farapulse: Smartbombs blasting AFib - MSNSAN DIEGO, Calif. (Ivanhoe Newswire) - Atrial fibrillation, or AFib, is the most common type of heart arrhythmia. It’s estimated 12 million people in the U.S. are living with it. If not treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results